Xylem (NYSE:XYL) Stock Price Target Lowered at JPMorgan Chase & Co.

Key Points

• JPMorgan lowered Xylem’s price target from $137 to $118 while maintaining a “neutral” rating, implying approximately 13.93% upside from the stock’s $103.57 price.
• Analyst sentiment remains mixed but moderately positive: Xylem has eight Buy and eight Hold ratings, with an average target price of $140.85.
• Xylem recently exceeded quarterly EPS expectations, reporting $1.46 versus the $1.34 consensus estimate, while revenue matched forecasts at $2.34 billion. Institutional investors own approximately 87.96% of the company.

Xylem (NYSE:XYL - Get Free Report) had its price target cut by analysts at JPMorgan Chase & Co. from $137.00 to $118.00 in a note issued to investors on Monday, Benzinga reports. The firm presently has a "neutral" rating on the industrial products company's stock. JPMorgan Chase & Co.'s target price would indicate a potential upside of 13.93% from the stock's current price.

A number of other research firms also recently issued reports on XYL. CLSA upgraded shares of Xylem to a "hold" rating in a research report on Thursday, June 25th. Royal Bank Of Canada lowered their price target on shares of Xylem from $164.00 to $135.00 and set an "outperform" rating on the stock in a report on Wednesday, October 14th. UBS Group lowered their price target on shares of Xylem from $138.00 to $112.00 and set a "neutral" rating on the stock in a report on Monday, October 5th. Barclays dropped their price target on shares of Xylem from $159.00 to $139.00 and set an "overweight" rating on the stock in a research note on Tuesday, October 13th. Finally, Mizuho cut their price objective on Xylem from $130.00 to $110.00 and set a "neutral" rating for the company in a report on Thursday. Eight research analysts have rated the stock with a Buy rating and eight have issued a Hold rating to the company's stock. Based on data from MarketBeat.com, Xylem has an average rating of "Moderate Buy" and an average target price of $140.85.

Xylem Stock Down 0.5%

NYSE:XYL traded down $0.48 on Monday, hitting $103.57. 1,227,061 shares of the company's stock traded hands, compared to its average volume of 2,069,116. The company has a market cap of $24.18 billion, a PE ratio of 24.66, a price-to-earnings-growth ratio of 1.67 and a beta of 1.00. Xylem has a 1 year low of $98.58 and a 1 year high of $154.27. The company has a current ratio of 1.61, a quick ratio of 1.24 and a debt-to-equity ratio of 0.23. The firm has a 50-day moving average price of $108.40 and a 200-day moving average price of $113.89.

Xylem (NYSE:XYL - Get Free Report) last posted its quarterly earnings results on Tuesday, July 28th. The industrial products company reported $1.46 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.34 by $0.12. The business had revenue of $2.34 billion during the quarter, compared to analyst estimates of $2.34 billion. Xylem had a net margin of 11.15% and a return on equity of 11.77%. The firm's revenue was up 1.5% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.26 earnings per share. Xylem has set its FY 2026 guidance at 5.550-5.700 EPS. Equities analysts anticipate that Xylem will post 5.66 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently modified their holdings of the business. State Street Corp grew its holdings in shares of Xylem by 2.4% during the 2nd quarter. State Street Corp now owns 11,444,669 shares of the industrial products company's stock worth $1,352,874,000 after purchasing an additional 270,972 shares in the last quarter. XXEC Inc. increased its position in shares of Xylem by 477.9% during the first quarter. XXEC Inc. now owns 171,211 shares of the industrial products company's stock valued at $20,460,000 after purchasing an additional 141,586 shares during the period. NFJ Investment Group LLC acquired a new position in shares of Xylem in the second quarter valued at $4,116,000. Entropy Technologies LP raised its stake in shares of Xylem by 45.7% in the first quarter. Entropy Technologies LP now owns 36,956 shares of the industrial products company's stock valued at $4,416,000 after purchasing an additional 11,583 shares in the last quarter. Finally, Perpetual Ltd raised its stake in shares of Xylem by 10.2% in the third quarter. Perpetual Ltd now owns 129,946 shares of the industrial products company's stock valued at $13,160,000 after purchasing an additional 11,993 shares in the last quarter. Institutional investors and hedge funds own 87.96% of the company's stock.

Xylem Company Profile

Xylem Inc NYSE: XYL is a global water technology company that develops products and services for the transportation, treatment, testing and efficient use of water and wastewater. Its offerings support municipal water and wastewater utilities, industrial customers, commercial facilities and residential applications.

The company's products and solutions include water and wastewater pumps, treatment systems, dewatering equipment, smart meters, monitoring and control technologies, leak detection tools, and data-driven analytics.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.